Medicine:DTaP-Hib vaccine

From HandWiki
Revision as of 00:30, 5 February 2024 by Jport (talk | contribs) (correction)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Combination vaccine
DTaP-Hib vaccine
Combination of
DTaP vaccineVaccine
Hib vaccineVaccine
Clinical data
Trade namesTriHIBit, ActHIB with Tripedia
Pregnancy
category
  • US: C (Risk not ruled out)
Routes of
administration
Intramuscular injection
ATC code
Identifiers
CAS Number

DTaP-Hib vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed with Haemophilus B conjugate vaccine, sometimes abbreviated to DTaP-Hib.[1] It protects against the infectious diseases diphtheria, tetanus, pertussis, and Haemophilus influenzae type B.[citation needed]

A branded formulation was marketed in the US as TriHIBit by Sanofi Pasteur, and administered by using the Sanofi DTaP vaccine Tripedia to reconstitute the Sanofi Hib vaccine ActHIB.[2][3][4] TriHIBit and Tripedia were discontinued in 2011.[5] The current Sanofi DTaP formulation is Daptacel.[citation needed]

References